Diseases, Conditions, Syndromes

Scientists discover workings of first promising Marburg virus treatment

With a mortality rate of up to 88 percent, Marburg virus can rip through a community in days. In 2005, an outbreak of Marburg virus struck a pediatric ward in the country of Angola. With no treatment available, doctors struggled ...

Diseases, Conditions, Syndromes

Experimental Ebola antibody protects monkeys

Scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, and colleagues have discovered that a single monoclonal antibody—a protein that attacks viruses—isolated ...

Diseases, Conditions, Syndromes

Experts highlight Ebola vaccine progress and suggest next steps

Despite promising advances, important scientific questions remain unanswered in the effort to develop a safe and effective Ebola vaccine, according to members of an international Ebola research consortium. In a Viewpoint ...

Diseases, Conditions, Syndromes

DR Congo identifies 'second wave' of Ebola in east

A second wave of the Ebola virus has been confirmed in eastern Democratic Republic of Congo, where an initial outbreak has already killed 125 people, a minister said Saturday.

Diseases, Conditions, Syndromes

Marburg virus vaccine shows promising results in first-in-human study

A newly published paper in The Lancet shows that an experimental vaccine against Marburg virus (MARV) was safe and induced an immune response in a small, first-in-human clinical trial. The vaccine, developed by researchers ...

Diseases, Conditions, Syndromes

WHO identifying potential pandemic pathogens

The World Health Organization said on Monday it was thrashing out a new list of priority pathogens that risk sparking pandemics or outbreaks and should be kept under close observation.

page 10 from 40